(Q3)Jun 30, 2024 | (Q2)Mar 31, 2024 | (Q1)Dec 31, 2023 | (FY)Sep 30, 2023 | (Q4)Sep 30, 2023 | (Q3)Jun 30, 2023 | (Q2)Mar 31, 2023 | (Q1)Dec 31, 2022 | (FY)Sep 30, 2022 | (Q4)Sep 30, 2022 | |
---|---|---|---|---|---|---|---|---|---|---|
Operating Cash Flow (Indirect Method) | ||||||||||
Cash flow from continuing operating activities | -726.08%-667.63K | 88.20%-497.78K | 46.47%-590.46K | 29.01%-2.06M | 362.72%3.34M | -165.73%-80.82K | -351.11%-4.22M | -66.16%-1.1M | 17.87%-2.9M | -266.02%-1.27M |
Net income from continuing operations | -23.19%-1.5M | 34.53%-752.14K | 30.44%-875.81K | -12.21%-3.07M | 159.66%556.26K | -118.78%-1.22M | -40.54%-1.15M | -193.64%-1.26M | 49.77%-2.73M | 16.07%-932.32K |
Operating gains losses | 237.56%67.89K | ---330.98K | --103.31K | ---- | ---- | --20.11K | ---- | ---- | ---276.47K | --0 |
Depreciation and amortization | -97.63%627 | 0.00%26.42K | -32.00%17.96K | 0.67%105.67K | -39.03%26.42K | 177.82%26.42K | -1.31%26.42K | 4.15%26.42K | -7.68%104.97K | -51.62%43.33K |
Asset impairment expenditure | -109.86%-5.35K | -85.41%55.03K | -44.92%121.48K | -48.29%607.62K | -108.93%-44.28K | -86.62%54.23K | 109.71%377.12K | 133.45%220.55K | 3.36%1.18M | 45.26%495.67K |
Remuneration paid in stock | 36.12%1.09M | 42.10%671.95K | 1,491.73%286.15K | 426.12%1.1M | -937.46%-190.82K | 2,087.58%802.23K | 778.59%472.86K | -81.32%17.98K | -79.42%209.51K | -80.47%22.79K |
Other non cashItems | ---- | ---- | ---- | -1,045.64%-248.31K | -2,269.92%-158.12K | -1,662.74%-100K | -51.04%3.14K | 8.49%6.67K | 10.76%26.26K | -67.39%7.29K |
Change In working capital | -238.56%-323.36K | 96.08%-168.05K | -110.58%-243.54K | 60.29%-558.59K | 497.47%3.61M | -32.29%233.36K | -1,015.26%-4.29M | 74.71%-115.65K | -269.22%-1.41M | -570.06%-909.27K |
-Change in receivables | 109.60%49.86K | 88.93%-55.97K | 36.34%-145.58K | 42.46%-659.58K | 113.66%51.02K | 105.05%23.79K | -125.92%-505.69K | -194.91%-228.7K | -15.99%-1.15M | 6.21%-373.57K |
-Change in prepaid assets | -319.63%-61.55K | -126.15%-15.35K | -91.06%19.37K | 190.07%325.13K | -89.80%21.6K | -89.69%28.03K | 108.23%58.69K | 264.94%216.82K | -219.20%-360.98K | -27.19%211.63K |
-Change in payables and accrued expense | -271.67%-311.66K | 97.48%-96.74K | -13.07%-117.34K | -322.93%-224.14K | 573.89%3.54M | -66.63%181.55K | -795.99%-3.84M | 58.21%-103.77K | -66.97%100.54K | -348.20%-747.33K |
Cash from discontinued investing activities | ||||||||||
Operating cash flow | -269.22%-667.63K | 88.20%-497.78K | 46.47%-590.46K | 29.01%-2.06M | 370.57%3.44M | -494.53%-180.82K | -351.11%-4.22M | -66.16%-1.1M | 17.87%-2.9M | -266.02%-1.27M |
Investing cash flow | ||||||||||
Cash flow from continuing investing activities | 41.17%-666.51K | -133.86%-669.94K | -154.68%-954.27K | 72.66%-1.83M | -8,922.46%-4.42M | 69.19%-1.13M | 200.16%1.98M | 274.33%1.75M | -165.03%-6.7M | 94.90%-49.03K |
Capital expenditure reported | ---- | ---- | ---- | -36.00%-8.55M | ---- | ---- | ---- | ---- | ---6.29M | --247.58K |
Net PPE purchase and sale | 39.07%-666.62K | -132.10%-649.19K | -145.53%-811.43K | 2,907.31%6.9M | 20,575.01%4.19M | -134.53%-1.09M | 203.99%2.02M | 283.03%1.78M | -97.79%229.53K | 99.65%-20.48K |
Net other investing changes | 100.29%111 | 52.50%-20.75K | -289.32%-142.85K | 71.83%-181.31K | 77.53%-62.06K | 87.43%-38.88K | -42.18%-43.68K | -33.33%-36.69K | -564.82%-643.69K | -272.52%-276.14K |
Cash from discontinued investing activities | ||||||||||
Investing cash flow | 41.17%-666.51K | -133.86%-669.94K | -154.68%-954.27K | 72.66%-1.83M | -8,922.46%-4.42M | 69.19%-1.13M | 200.16%1.98M | 274.33%1.75M | -165.03%-6.7M | 94.90%-49.03K |
Financing cash flow | ||||||||||
Cash flow from continuing financing activities | 0 | -99.37%145K | 0 | 3,211.04%22.33M | 9.82K | 0 | 23.01M | -681.36K | 674.56K | |
Net issuance payments of debt | --0 | --0 | --0 | -200.62%-678.76K | --9.82K | --0 | ---7.22K | ---681.36K | --674.56K | ---- |
Net common stock issuance | --0 | ---- | ---- | --23.01M | --0 | --0 | ---- | ---- | --0 | ---- |
Proceeds from stock option exercised by employees | --0 | ---- | ---- | ---- | ---- | --0 | ---- | ---- | ---- | ---- |
Cash from discontinued financing activities | ||||||||||
Financing cash flow | --0 | -99.37%145K | --0 | 3,211.04%22.33M | --9.82K | --0 | --23.01M | ---681.36K | --674.56K | ---- |
Net cash flow | ||||||||||
Beginning cash position | -24.72%15.9M | 3,180.51%16.53M | 7,294.05%18.42M | -97.38%249.17K | 1,090.65%19.47M | 293.67%21.12M | -93.59%503.82K | -97.38%249.17K | 245.45%9.5M | -85.16%1.64M |
Current changes in cash | -9.91%-1.33M | -104.92%-1.02M | -3,841.94%-1.54M | 306.48%18.44M | -65.53%-1.07M | 67.27%-1.21M | 813.37%20.77M | 97.65%-39.19K | -231.84%-8.93M | 50.57%-647K |
Effect of exchange rate changes | 136.17%157.98K | 359.38%392.99K | -219.43%-350.94K | 16.61%-267.46K | 103.65%26.97K | -1,974.08%-436.76K | -136.34%-151.51K | 1,220.63%293.84K | -1,253.90%-320.73K | -250.71%-738.87K |
End cash Position | -24.38%14.72M | -24.72%15.9M | 3,180.51%16.53M | 7,294.05%18.42M | 7,294.05%18.42M | 1,090.65%19.47M | 293.67%21.12M | -93.59%503.82K | -97.38%249.17K | -97.38%249.17K |
Free cash from | -4.65%-1.33M | 47.79%-1.15M | 77.48%-1.4M | -15.23%-10.61M | 12.12%-918.72K | 65.06%-1.27M | 23.72%-2.2M | -280.10%-6.22M | 1.24%-9.21M | 15.33%-1.05M |
Accounting Standards | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP |
Audit Opinions | -- | -- | -- | Unqualified Opinion | -- | -- | -- | -- | Unqualified Opinion | -- |
FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.
Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.
No Data